Recruiting Atopic Dermatitis Studies in Miami Lakes
A Study of Barzolvolimab in Patients With Atopic Dermatitis
The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with Atopic Dermatitis...
Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab
Multicenter, randomized, double-blind, placebo-controlled, parallel arm clinical study designed to evaluate the efficacy and safety of eblasakimab in participants with moderate-to-severe atopic dermat...
About Atopic Dermatitis Clinical Trials in Miami Lakes
Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.
There are currently 2 atopic dermatitis clinical trials recruiting participants in Miami Lakes, FL. These studies are seeking a combined 195 participants. Research is being sponsored by Celldex Therapeutics, ASLAN Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Atopic Dermatitis Clinical Trials in Miami Lakes — FAQ
Are there atopic dermatitis clinical trials in Miami Lakes?
Yes, there are 2 atopic dermatitis clinical trials currently recruiting in Miami Lakes, FL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Miami Lakes?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami Lakes research site will contact you about next steps.
Are clinical trials in Miami Lakes free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miami Lakes studies also compensate for your time and travel.
What atopic dermatitis treatments are being tested?
The 2 active trials in Miami Lakes are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.
Data updated March 2, 2026 from ClinicalTrials.gov